Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Publication of Prospectus

24th Oct 2007 17:00

Aricom PLC24 October 2007 Press Release 24 October 2007 Aricom plc ("Aricom" or "the Company" and together with its subsidiaries the "Group") Announcement of publication of prospectus for the Company's move from AIM to the Official List and the Main Market Aricom today announces the publication of the approved prospectus in relation tothe Company's proposed move from AIM to the Main Market and primary listing ofits ordinary shares ("Ordinary Shares") and outstanding warrants ("Warrants") onthe Official List of the UK Listing Authority (the "Official List") andadmission to trading on the London Stock Exchange plc's Main Market for listedsecurities (the "Main Market"). Admission of its Ordinary Shares and Warrantsto the Official List and commencement of trading on the Main Market is expectedto occur on Monday, 29 October, 2007 at 8:00am. The Company's Ordinary Shareswill trade under the ticker "ORE" and the Company's Warrants will trade underthe ticker "OREW". The Company wishes to notify shareholders that trading ofits Ordinary Shares on AIM under ticker "TIO" will be cancelled simultaneouslywith its admission to the Main Market. JPMorgan Cazenove Limited and Canaccord Adams Limited have been appointed asjoint sponsors and joint financial advisers in relation to the admission to theOfficial List and move to the Main Market and will be acting as joint brokers tothe Company. - Ends - For further information:Aricom plcJay Hambro, Chief Executive Tel: +44 (0) 20 7201 8939 www.aricom.plc.ukJPMorgan CazenoveIan Hannam / Patrick Magee Tel: +44 (0) 20 7155 2828 www.jpmorgancazenove.comCanaccord AdamsRobert Finlay / Chris Bowman Tel: +44 (0) 20 7050 6500 www.canaccordadams.com Abchurch Tel: +44 (0) 20 7398 7700Charlie Jack/ George Parker www.abchurch-group.com This announcement is an advertisement and not a prospectus and investors shouldnot subscribe for or purchase any securities referred to in this announcementexcept on the basis of information in the prospectus which has been published bythe Company (the "Prospectus") in connection with the admission of its OrdinaryShares and Warrants to the Official List and to trading on the Main Market ("Admission"). Copies of the Prospectus are available from the offices of Aricomplc 10-11 Grosvenor Place, London, SW1X 7HH. The Company is not offering any new Ordinary Shares, Warrants or othersecurities in connection with Admission. This document does not constitute anoffer to sell, or the solicitation of an offer to subscribe for or buy OrdinaryShares, Warrants or other securities in any jurisdiction. The contents of this announcement have been prepared by and are the soleresponsibility of the Company. JPMorgan Cazenove and Canaccord which areauthorised and regulated in the United Kingdom by the FSA have been appointed asJoint Financial Advisers and Joint Sponsors to the Company. JPMorgan Cazenoveand Canaccord are advising the Company and no-one else in connection withAdmission and will not be responsible to anyone other than the Company forproviding the protections afforded to the clients of JPMorgan Cazenove orCanaccord or for affording advice in relation to Admission, the contents of thisannouncement or any transaction or arrangement referred to herein. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Orogen Gold
FTSE 100 Latest
Value8,275.66
Change0.00